YS Biopharma (YS) Institutional Ownership → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free YS Stock Alerts $0.95 -0.08 (-7.77%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for YS Biopharma (NASDAQ:YS)CurrentInstitutional OwnershipPercentage52.64%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$4.45MNumber ofInstitutional Sellers(last 12 months)0 Get YS Insider Trade Alerts Want to know when executives and insiders are buying or selling YS Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data YS Institutional Buying and Selling by Quarter Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… YS Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024 Superstring Capital Management LP307,920$166K0.1%N/A0.331% 9/21/2023 Barclays PLC108,894$150K0.0%N/A0.423% 8/14/2023 Prelude Capital Management LLC32,200$44K0.0%N/A0.125% 5/16/2023 Snow Lake Management LP1,811,942$2.90M1.7%N/A7.037% 5/16/2023 Hhlr Advisors LTD.751,790$1.20M0.0%N/A2.920% 5/15/2023 RTW Investments LP341,090$546K0.0%N/A1.325% 5/11/2023 FIL Ltd2,718,499$4.35M0.0%N/A10.557% 5/10/2023 Valliance Asset Management Ltd1,607,175$2.57M4.6%N/A6.241% (Data available from 1/1/2016 forward) YS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of YS shares? During the previous two years, the following institutional investors and hedge funds held shares of YS Biopharma shares: FIL Ltd ($4.35M), Snow Lake Management LP ($2.90M), Valliance Asset Management Ltd ($2.57M), Hhlr Advisors LTD. ($1.20M), RTW Investments LP ($546K), Superstring Capital Management LP ($166K), and Barclays PLC ($150K).Learn more on YS's institutional investors. What percentage of YS Biopharma stock is owned by institutional investors? 52.64% of YS Biopharma stock is owned by institutional investors. Learn more on YS's institutional investor holdings. Which institutional investors have been buying YS Biopharma stock? The following institutional investors have purchased YS Biopharma stock in the last 24 months: FIL Ltd ($2.72M), Snow Lake Management LP ($1.81M), Valliance Asset Management Ltd ($1.61M), Hhlr Advisors LTD. ($751.79K), RTW Investments LP ($341.09K), Superstring Capital Management LP ($307.92K), and Barclays PLC ($108.89K). How much institutional buying is happening at YS Biopharma? Institutional investors have bought a total of 7,679,510 shares in the last 24 months. This purchase volume represents approximately $11.92M in transactions. Related Companies: ProPhase Labs Institutional Ownership Eton Pharmaceuticals Institutional Ownership Oncolytics Biotech Institutional Ownership Vaccitech Institutional Ownership Q32 Bio Institutional Ownership Aclaris Therapeutics Institutional Ownership Milestone Pharmaceuticals Institutional Ownership Chimerix Institutional Ownership LifeVantage Institutional Ownership BeyondSpring Institutional Ownership This page (NASDAQ:YS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & CompanyWhy Is Gold On a MASSIVE rally? Huge AlertsProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.